A Predictive Model for Triple Negative Optic Neuritis Patients: Identifying the Subset of Patients With Favorable Outcomes
Ariel Rechtman1, Tal Friedman Korn3, Omri Zveik4, sol zamir2, Netta Levin4, adi vaknin5
1Hadassah-Hebrew University Medical Center, 2neurology, Hadassah-Hebrew University Medical Center, 3Mass General Brigham, 4Hadassah Hebrew University Hospital, 5Hadassah Medical Center
Objective:
This study aimed to characterize triple-negative ON (TNON) cases and compare them to MS, MOGAD, and NMOSD.
Background:
A subset of optic neuritis (ON) patients remains seronegative for AQP4-IgG, MOG-IgG, and CSF oligoclonal bands (OCBs), complicating diagnosis and management. We refer to this group as triple-negative optic neuritis (TNON).
Design/Methods:
We retrospectively analyzed 103 patients with a first ON episode tested for AQP4-IgG, MOG-IgG, and OCBs, classifying them into MS (n=26), MOGAD (n=25), NMOSD (n=13), and TNON (n=39). TNON was further divided into evolving MS (evMS) and idiopathic TNON. A support vector machine (SVM) was used to classify TNON based on onset data.
Results:
TNON patients showed less optic disc edema and radiological involvement than MOGAD and responded more poorly to steroids. However, TNON had lower relapse rates and less need for chronic treatment than MS or NMOSD. SVM analysis revealed that most evMS cases clustered with MS, while idiopathic TNON aligned more closely with MOGAD.
Conclusions:
TNON is a heterogeneous entity encompassing both early MS and a distinct idiopathic subgroup. While clinical features alone could not differentiate these subgroups, our predictive model successfully stratified them at onset. Idiopathic TNON may reflect an undetected antibody-mediated process with a generally favorable prognosis.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.